TARDBP and amyotrophic lateral sclerosis: In contrast to the above findings, an ALS patient with CHCHD10 R15L mutation, who experienced slowly progressive limb weakness and dysphagia, meeting the El Escorial criteria for clinically probable ALS, had no TDP-43-immunopositive inclusions (Keith et al., 2020).